These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Phenotypic changes in rat and guinea pig coronary microvascular endothelium after culture: loss of nitric oxide synthase activity. Lang D; Bell JP; Bayraktutan U; Small GR; Shah AM; Lewis MJ Cardiovasc Res; 1999 Jun; 42(3):794-804. PubMed ID: 10533620 [TBL] [Abstract][Full Text] [Related]
45. Bradykinin stimulates the production of cyclic GMP via activation of B2 kinin receptors in cultured porcine aortic endothelial cells. Schini VB; Boulanger C; Regoli D; Vanhoutte PM J Pharmacol Exp Ther; 1990 Feb; 252(2):581-5. PubMed ID: 2156053 [TBL] [Abstract][Full Text] [Related]
50. Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress. Russo I; Del Mese P; Doronzo G; Mattiello L; Viretto M; Bosia A; Anfossi G; Trovati M Endocrinology; 2008 Apr; 149(4):1480-9. PubMed ID: 18079207 [TBL] [Abstract][Full Text] [Related]
51. NG-methyl-L-arginine causes endothelium-dependent contraction and inhibition of cyclic GMP formation in artery and vein. Gold ME; Wood KS; Byrns RE; Fukuto J; Ignarro LJ Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4430-4. PubMed ID: 2162040 [TBL] [Abstract][Full Text] [Related]
52. Muscarinic receptor-mediated prostacyclin and cGMP synthesis in cultured vascular cells. Jaiswal N; Jaiswal RK; Malik KU Mol Pharmacol; 1991 Jul; 40(1):101-6. PubMed ID: 1677448 [TBL] [Abstract][Full Text] [Related]
53. Promotion of nitric oxide formation by heparin in cultured aortic endothelial cells from spontaneously hypertensive rats. Minami M; Yokokawa K; Kohno M; Ikeda M; Horio T; Kano H; Hanehira T; Yasunari K; Takeda T Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S146-7. PubMed ID: 9072331 [TBL] [Abstract][Full Text] [Related]
54. Nitric oxide-evoked transient kinetics of cyclic GMP in vascular smooth muscle cells. Cawley SM; Sawyer CL; Brunelle KF; van der Vliet A; Dostmann WR Cell Signal; 2007 May; 19(5):1023-33. PubMed ID: 17207606 [TBL] [Abstract][Full Text] [Related]
56. Role of endothelium-derived bradykinin in the control of vascular tone. Hecker M; Dambacher T; Busse R J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S55-61. PubMed ID: 1282631 [TBL] [Abstract][Full Text] [Related]
57. Factors contributing to differences in the regulation of cGMP in isolated porcine pulmonary vessels. Bina S; Hart JL; Sei Y; Muldoon SM Eur J Pharmacol; 1998 Jun; 351(2):253-60. PubMed ID: 9687010 [TBL] [Abstract][Full Text] [Related]
58. Stimulation of vascular Na(+)-K(+)-ATPase activity by nitric oxide: a cGMP-independent effect. Gupta S; McArthur C; Grady C; Ruderman NB Am J Physiol; 1994 May; 266(5 Pt 2):H2146-51. PubMed ID: 7911280 [TBL] [Abstract][Full Text] [Related]
59. Relaxation induced by calcium ionophore is impaired in carotid arteries from 2K-1C rats due to failed effect of nitric oxide on the smooth muscle cells. Oliveira AP; Lunardi CN; Rodrigues GJ; Bendhack LM Vascul Pharmacol; 2009; 50(5-6):153-9. PubMed ID: 19100862 [TBL] [Abstract][Full Text] [Related]